Clopidogrel "Aurobindo" 75 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

clopidogrel "aurobindo" 75 mg filmovertrukne tabletter

aurobindo pharma (malta) limited - clopidogrelhydrogensulfat - filmovertrukne tabletter - 75 mg

Clopidogrel "Orion" 75 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

clopidogrel "orion" 75 mg filmovertrukne tabletter

orion corporation - clopidogrelhydrogensulfat - filmovertrukne tabletter - 75 mg

Platel 75 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

platel 75 mg filmovertrukne tabletter

medochemie ltd. - clopidogrelhydrogensulfat - filmovertrukne tabletter - 75 mg

Plavix Den Europæiske Union - dansk - EMA (European Medicines Agency)

plavix

sanofi winthrop industrie - clopidogrelhydrogensulfat - stroke; peripheral vascular diseases; atrial fibrillation; myocardial infarction; acute coronary syndrome - antitrombotiske midler - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in patients undergoing percutaneous coronary intervention (including patients undergoing a stent replacement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. in patients with moderate to high-risk transient ischemic attack (tia) or minor ischemic stroke (is)clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event. forebyggelse af atherothrombotic og tromboemboliske hændelser i atrial fibrillationin voksne patienter med atrieflimren, der har mindst en risikofaktor for vaskulære hændelser, er ikke egnede til behandling med vitamin-k-antagonister, og som har en lav risiko for blødning, clopidogrel er indiceret i kombination med asa til forebyggelse af atherothrombotic og tromboemboliske hændelser, herunder slagtilfælde.

Agregex 75 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

agregex 75 mg filmovertrukne tabletter

actavis group ptc ehf. - clopidogrelhydrogensulfat - filmovertrukne tabletter - 75 mg

Clopidogrel "Accord" 75 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

clopidogrel "accord" 75 mg filmovertrukne tabletter

accord healthcare b.v. - clopidogrelhydrogensulfat - filmovertrukne tabletter - 75 mg

Clopidogrel "Aristo" 75 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

clopidogrel "aristo" 75 mg filmovertrukne tabletter

aristo pharma gmbh - clopidogrelhydrogensulfat - filmovertrukne tabletter - 75 mg

Clopidogrel "GSK" 75 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

clopidogrel "gsk" 75 mg filmovertrukne tabletter

glaxosmithkline pharma a/s - clopidogrelhydrogensulfat - filmovertrukne tabletter - 75 mg

Clopidogrel "Pliva" 75 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

clopidogrel "pliva" 75 mg filmovertrukne tabletter

pliva pharma ltd. - clopidogrelhydrogensulfat - filmovertrukne tabletter - 75 mg

Clopidogrel "Splendris" 75 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

clopidogrel "splendris" 75 mg filmovertrukne tabletter

splendris pharmaceuticals gmbh - clopidogrelhydrogensulfat - filmovertrukne tabletter - 75 mg